ERBB2 and breast cancer: HR+/HER2− (Luminal A) breast cancers are the most common subtype, followed by the triple-negative (TNBC), HR+/HER2+ (Luminal B) and HR−/HER2+ (HER2+) subtypes, in that order [107].